Arcadia Biosciences Stock Price on October 31, 2023
| RKDA Stock | USD 6.04 0.36 5.63% |
Below is the normalized historical share price chart for Arcadia Biosciences extending back to May 15, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arcadia Biosciences stands at 6.04, as last reported on the 11th of December 2024, with the highest price reaching 6.04 and the lowest price hitting 6.04 during the day.
If you're considering investing in Arcadia Stock, it is important to understand the factors that can impact its price. Arcadia Biosciences is very risky given 3 months investment horizon. Arcadia Biosciences secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of standard deviation over the last 3 months. We were able to break down twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.93% are justified by taking the suggested risk. Use Arcadia Biosciences mean deviation of 6.03, and Risk Adjusted Performance of 0.1078 to evaluate company specific risk that cannot be diversified away.
At present, Arcadia Biosciences' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 1.3 M, whereas Other Stockholder Equity is forecasted to decline to about 207.1 M. . At present, Arcadia Biosciences' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price To Sales Ratio is forecasted to decline to 0.69. Arcadia Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of May 2015 | 200 Day MA 2.8586 | 50 Day MA 3.4118 | Beta 1.275 |
Arcadia |
Sharpe Ratio = 0.1346
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | RKDA | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 14.33 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.93 actual daily | 38 62% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Arcadia Biosciences is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arcadia Biosciences by adding it to a well-diversified portfolio.
Price Book 0.7338 | Enterprise Value Ebitda 0.6173 | Price Sales 1.5906 | Shares Float 1.4 M | Wall Street Target Price 9 |
Related Headline
Laird Superfood Headline on 31st of October 2023
Filed transaction by Laird Superfood Inc director. Payment of exercise price or tax liability by delivering or withholding securities
Arcadia Biosciences Valuation on October 31, 2023
It is possible to determine the worth of Arcadia Biosciences on a given historical date. On October 31, 2023 Arcadia was worth 3.37 at the beginning of the trading date compared to the closed value of 3.43. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arcadia Biosciences stock. Still, in general, we apply an absolute valuation method to find Arcadia Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arcadia Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arcadia Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 3.45 | 3.55 | 3.36 | 3.43 | 7,694 | |
10/31/2023 | 3.37 | 3.43 | 3.36 | 3.43 | 6,538 |
| 3.44 | 3.44 | 3.25 | 3.25 | 1,200 |
| Backtest Arcadia Biosciences | | | Arcadia Biosciences History | | | Arcadia Biosciences Valuation | Previous | Next |
Arcadia Biosciences Trading Date Momentum on October 31, 2023
| On November 01 2023 Arcadia Biosciences was traded for 3.25 at the closing time. The top price for the day was 3.44 and the lowest listed price was 3.25 . The trading volume for the day was 1.2 K. The trading history from November 1, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 5.25% . The overall trading delta against the current closing price is 2.33% . |
Arcadia Biosciences Fundamentals Correlations and Trends
By evaluating Arcadia Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arcadia Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arcadia financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Arcadia Biosciences Stock history
Arcadia Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arcadia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arcadia Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arcadia Biosciences stock prices may prove useful in developing a viable investing in Arcadia Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.2 M | 1.3 M | |
| Net Loss | -16.9 M | -17.7 M |
Arcadia Biosciences Quarterly Net Working Capital |
|
Arcadia Biosciences Stock Technical Analysis
Arcadia Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Arcadia Biosciences Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Arcadia Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Arcadia Biosciences December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Arcadia Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arcadia Biosciences shares will generate the highest return on investment. By undertsting and applying Arcadia Biosciences stock market strength indicators, traders can identify Arcadia Biosciences entry and exit signals to maximize returns
Arcadia Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arcadia Biosciences' price direction in advance. Along with the technical and fundamental analysis of Arcadia Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arcadia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1078 | |||
| Jensen Alpha | 1.93 | |||
| Total Risk Alpha | (0.32) | |||
| Sortino Ratio | 0.2591 | |||
| Treynor Ratio | (8.79) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Arcadia Stock analysis
When running Arcadia Biosciences' price analysis, check to measure Arcadia Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcadia Biosciences is operating at the current time. Most of Arcadia Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcadia Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcadia Biosciences' price. Additionally, you may evaluate how the addition of Arcadia Biosciences to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |